Human metapneumovirus cases surge in China: All about the virus that’s triggering an epidemic like situation

Cases related to pathogens such as the rhinovirus and human metapneumovirus are increasing in China. As per reports, China is currently dealing with a fresh outbreak of viruses with the emergence of various respiratory infectious diseases in winter.
“Recent cases detected include pathogens such as the rhinovirus and human metapneumovirus, with cases of the human metapneumovirus among people under the age of 14 showing an upward trend, especially in northern provinces,” as per a report published in Reuters.
Health experts have urged people not to use antiviral drugs blindly. In a recent interview with the state-backed National Business Daily, a prominent respiratory expert from a Shanghai hospital cautioned the public against the indiscriminate use of antiviral drugs to combat human metapneumovirus (HMPV). This virus, for which there is no vaccine, often presents symptoms like those of the common cold, including cough, congestion, and fever. The use of antiviral drugs in blindly may lead to a number of other health consequences and even drug resistance.

Human metapneumovirus (HMPV) is a respiratory virus within the Paramyxoviridae family. First identified in 2001, it is one of the most common causes of respiratory infections, especially in young children, the elderly, and immunocompromised individuals. HMPV is related to respiratory syncytial virus (RSV) and is characterized by symptoms similar to those of the common cold.
Some common symptoms in cases of infection from this virus include coughing, runny nose, fever, difficulty in breathing, and fatigue. However, with weakened immunity in populations, HMPV is reported to trigger conditions such as bronchitis and pneumonia. Until now, no specific vaccination or antiviral treatment exists for HMPV. Preventive measures like washing hands, avoiding contact with infected individuals can save one from getting infected.